doi:10.3969/j.issn.1004-583X.2021.12.017

Abstract

CLC Number:

R459.5

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2021.12.017

https://huicui.hebmu.edu.cn/EN/Y2021/V36/I12/1136

References 27

[1]	Krediet RT. Peritoneal dialysis: From bench to bedside[J]. Clin Kidney J, 2013, 6(6):568-577. doi: 10.1093/ckj/sft122 URL
[2]	Li PK, Chow KM, Van de Luijtgaarden MW, et al. Changes in the worldwide epidemiology of peritoneal dialysis[J]. Nat Rev Nephrol, 2017, 13(2):90-103. doi: 10.1038/nrneph.2016.181 URL
[3]	Morton RL, Tong A, Webster AC, et al. Characteristics of dialysis important to patients and family caregivers: A mixed methods approach[J]. Nephrol Dial Transplant, 2011, 26(12):4038-4046. doi: 10.1093/ndt/gfr177 URL
[4]	Campbell D, Mudge DW, Craig JC, et al. Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients[J]. Cochrane Database Syst Rev, 2017, 4(6): CD004679.
[5]	Morton RL, Tong A, Webster AC, et al. Characteristics of dialysis important to patients and family caregivers: A mixed methods approach[J]. Nephrol Dial Transplant, 2011, 26(12):4038-4046. doi: 10.1093/ndt/gfr177 URL
[6]	Heal J. Underutilization of peritoneal dialysis[J]. JAMA, 2004, 291(6):740-742. doi: 10.1001/jama.291.6.740 URL
[7]	Annigeri R, Conly J, Vas S, et al. Emergence of mupirocin-resistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit-site infection[J]. PeTit Dial Int, 2001, 21(6):554-559.
[8]	Kotsanas D, Polkinghorne KR, Korman TM, et al. Risk factors for peritoneal dialysis-related peritonitis: Can we reduce the incidence and improve patient selection?[J]. Nephrology (Carlton), 2007, 12(3):239-245. doi: 10.1111/nep.2007.12.issue-3 URL
[9]	Martin LC, Caramori JC, Femandes N, et al. Geographic and educational factors and risk of the first peritonitis episode in Brazilian Peritoneal Dialysis study(BRAZPD)patients[J]. Clin J Am Soc Nephrol, 2011, 6(8):1944-1951. doi: 10.2215/CJN.11431210 URL
[10]	余学清. 腹膜透析治疗学[M]. 北京: 科学技术文献出版社, 2008:144-156.
[11]	熊子波, 杨虹, 廖玉梅, 等. 腹膜透析相关性腹膜炎169例次临床分析及转归[J]. 临床肾脏病杂志, 2012, 12(2):63-66.
[12]	Al-Allak A, Jones R, Stiff R, et al. Long-term outcome of continuous ambulatory peritoneal dialysis (CAPD)peritonitis: Surgery can be avoided[J]. Ann R Coll Surg Engl, 2009, 91(2):118-122. doi: 10.1308/003588409X359088 URL
[13]	Piraino B, Bailie GR, Bernardini J, et al. Peritoneal dialysis-related infections recommendations: 2005 update[J]. Petit Dial Int, 2005, 25(2):107-131.
[14]	Australia K. CARI Guidelines(Caring for Australians with Renal mpairment)[J]. Nephrology (Carlton), 2005, 9(Suppl 3):S1-106. doi: 10.1111/nep.2004.9.issue-s3 URL
[15]	Parsons DP. Preoperative evaluation and risk management[J]. Clin Colon Rectal Surg, 2009, 22(1):5-13. doi: 10.1055/s-0029-1202870 URL
[16]	Zhang L, Badve SV, Pascoe EM, et al. The effect of exit-site antibacterial honey versus nasal mupirocin prophylaxis on the microbiology and outcomes of peritoneal dialysis-associated peritonitis and exit-site infections: A sub-study of the honeypot trial[J]. Perit Dial Int, 2015, 35(7):712-721. doi: 10.3747/pdi.2014.00206 URL
[17]	Walker A, Bannister K, George C, et al. KHA-CARI Guideline: Peritonitis treatment and prophylaxis[J]. Nephrology(Carlton), 2014, 19(2):69-71.
[18]	Bennett-Jones, Ludwig KA, Fisk MA, et al. Prophylactic antibiotics in surgery[J]. Anna Rev Med, 2019, 44(6):385-393.
[19]	Wikdahl AM, Engman U, Stegmayr BG, et al. One-dose cefuroxime i.v. and i.p.reduces microbial growth in PD patients after catheter insertion[J]. Nephrol Dial Transplant, 1997, 12(1):157-160. doi: 10.1093/ndt/12.1.157 URL
[20]	Gadallah MF, Ramdeen G, Mignone J, et al. Role of preoperative antibiotic prophylaxis in preventing postoperative peritonitis in newly placed peritoneal dialysis catheters[J]. Am J Kidney Dis, 2000, 36(5):1014-1019. pmid: 11054359
[21]	Campbell D, Mudge DW, Craig JC, et al. Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients[J]. Cochrane Database Syst Rev, 2017, 4(4):CD004679.
[22]	Lye WC, Lee EJ, Tan CC. Prophylactic antibiotics in the insertion of Tenckhoff catheters[J]. Scand J Urol Nephrol, 1992, 26(2):177-180. pmid: 1626207
[23]	陈崴, 姜宗培, 郑勋华, 等. 腹膜透析置管术预防性抗生素用药的前瞻性随机对照临床研究[J]. 中华肾脏病杂志, 2006(10):601-604.
[24]	郑佳麒, 熊子波, 熊祖应, 等. 不同抗生素用药方案在预防腹膜透析置管术后腹膜炎中的比较[J]. 中国血液净化, 2013, 12(8):415-418.
[25]	刘红梅, 姚强, 杨玉红, 等. 腹腔预防性应用抗生素对腹膜透析置管术后发生腹膜炎的临床探讨[J]. 中国冶金工业医学志, 2014, 31(1):4-6.
[26]	Htay H, Johnson DW, Wiggins KJ, et al. Biocompatible dialysis fluids for peritoneal dialysis[J]. Cochrane Database Syst Rev, 2018, 10(10): CD007554.
[27]	Campbell DJ, Johnson DW, Mudge DW, et al. Prevention of peritoneal dialysis-related infections[J]. Nephrol Dial Transplant, 2015, 30(9):1461-1472. doi: 10.1093/ndt/gfu313 URL

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 27

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	. [J]. Clinical Focus, 2023, 38(12): 1150-1152.
[2]	Gong Zhiqing, Lu Dongmei, Xing Guangqun. The predictive and prognostic potential of serum parathyroid hormone combined with the nutritional status score on peritoneal dialysis catheter-related peritonitis [J]. Clinical Focus, 2023, 38(11): 991-995.
[3]	. [J]. Clinical Focus, 2023, 38(11): 1038-1041.
[4]	Li Hengnan, Huang Yan, Zhao Yajuan, Hu Guicai. Correlation between serum CTRP5 and left ventricular diastolic dysfunction in patients with continuous ambulatory peritoneal dialysis and its diagnostic value [J]. Clinical Focus, 2023, 38(4): 324-329.
[5]	Tao Yang, Pan Qingquan, Li Yan. Evaluation of hemoperfusion and continuous renal replacement therapy in paraquat poisoning patients complicated with MODS [J]. Clinical Focus, 2023, 38(4): 330-334.
[6]	Zhang Hongtao, Wang Zhikui. Renal anemia in patients with maintenance peritoneal dialysis and Related Factors: A single-center study [J]. Clinical Focus, 2022, 37(12): 1099-1103.
[7]	. [J]. Clinical Focus, 2022, 37(6): 556-559.
[8]	Cheng Huidong, Si Bolin, Hua Qin, He Jianqiang, Gui Lanlan. Efficacy comparison between pull and surgical technique for removal of peritoneal dialysis catheter [J]. Clinical Focus, 2021, 36(12): 1097-1101.
[9]	Shang Qihang, Chen Huaqian. Relationship between eosinophil levels and carotid atherosclerosis in maintenance hemodialysis patients [J]. Clinical Focus, 2021, 36(1): 44-48.
[10]	Shi Youshan, Chen Tianhao. Pathogenic bacteria and etiological analysis of peritoneal dialysisassociated peritonitis in a single peritoneal dialysis center [J]. Clinical Focus, 2020, 35(11): 1010-1014.
[11]	Duan Hailing;Cui Xiangqin;Wang Zongbao;Liu Guanbin;Geng Mingliang. Clinical application of vitamin E combined with hemoperfusion in maintenance hemodialysis patients [J]. Clinical Focus, 2015, 30(11): 1288-1291.
[12]	Wei Qing;Liu Hong;Tang Rining;Liu Bicheng. Sevelamer on curative effect and endpoint events in hemodialysis patients--a meta analysis [J]. Clinical Focus, 2015, 30(9): 1008-1.0121e+007.
[13]	Jia Yanli;Wang Ying;Cheng Hao;Sun Yi. Level and influential factors of serum Klotho in maintenance hemodialysis patients [J]. Clinical Focus, 2015, 30(8): 928-931.
[14]	Xu Zhuoj ia;Zhan Cheng;Wang Kai. Identification and characterization of Staphylococcus epidermidis from hemodialysis patients with tunneled-cuffed central venous catheters and hemodialysis environment [J]. Clinical Focus, 2015, 30(3): 308-311.
[15]	. [J]. Clinical Focus, 2015, 30(3): 357-360.